Back
Novo Nordisk AS Vs. Biodexa Pharmaceuticals PLC Industry Stock Comparison
Sell
40
NVO
Novo Nordisk AS
Last Price:
131.20
Seasonality Move:
3.35%
Sell
20
BDRX
Biodexa Pharmaceuticals PLC
Last Price:
0.37
Seasonality Move:
-41.47%
Sell
40
Novo Nordisk AS (NVO)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
- The current Novo Nordisk AS [NVO] share price is $131.14. The Score for NVO is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- NVO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
20
Biodexa Pharmaceuticals PLC (BDRX)
is a Sell
Is Biodexa Pharmaceuticals PLC a Buy, Sell or Hold?
- The current Biodexa Pharmaceuticals PLC [BDRX] share price is $0.36. The Score for BDRX is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- BDRX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
NVO Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $131.14
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing selling pressure, which indicates risk of future bearish movement.
BDRX Stock Price Chart
What is Biodexa Pharmaceuticals PLC's stock price today?
-
The Biodexa Pharmaceuticals PLC share price today is $0.36
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BDRX is experiencing selling pressure, which indicates risk of future bearish movement.
NVO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.05 | Buy |
| Relative Strength Index (14 RSI): | 44.39 | Sell |
| Chaikin Money Flow: | -1766560 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (128.81 - 137.53) | Sell |
| Bollinger Bands (100): | (127.92 - 140.64) | Sell |
BDRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 19 | Sell |
| Chaikin Money Flow: | -82482 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.5 - 0.64) | Sell |
| Bollinger Bands (100): | (0.61 - 1.15) | Sell |
NVO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 134.9 | Sell |
| 20-day SMA: | 134.91 | Sell |
| 50-day SMA: | 134.97 | Sell |
| 200-day SMA: | 124.47 | Buy |
| 8-day EMA: | 134.02 | Sell |
| 20-day EMA: | 134.26 | Sell |
| 50-day EMA: | 134.35 | Sell |
| 200-day EMA: | 123.99 | Buy |
BDRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.49 | Sell |
| 20-day SMA: | 0.56 | Sell |
| 50-day SMA: | 0.71 | Sell |
| 200-day SMA: | 1.41 | Sell |
| 8-day EMA: | 0.47 | Sell |
| 20-day EMA: | 0.55 | Sell |
| 50-day EMA: | 0.69 | Sell |
| 200-day EMA: | 17.94 | Sell |
Novo Nordisk AS Earnings Growth & NVO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.70 per share, and an increase next year of $0.92 per share.
Biodexa Pharmaceuticals PLC Earnings Growth & BDRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and an increase next year of $0.05 per share.
Novo Nordisk AS Technical Analysis
| Aug 23 | Aug 26 | Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 23 | 26 | 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Biodexa Pharmaceuticals PLC Technical Analysis
| Aug 23 | Aug 26 | Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 23 | 26 | 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||